(Q44743920)

5 December 2017

Enalapril in children with Alport syndrome (English)

1 reference

5 December 2017

1 reference

1 reference

Willem Proesmans

1

1 reference

PubMed ID

14745635

5 December 2017

Maria Van Dyck

series ordinal

2

1 reference

5 December 2017

24 January 2004

1 reference

5 December 2017

1 reference

5 December 2017

19

1 reference

5 December 2017

3

1 reference

5 December 2017

271-275

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-003-1366-z

5 December 2017

0 references

cites work

Enalapril in paediatric patients with Alport syndrome: 2 years' experience

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition in the prevention and treatment of chronic renal damage in the hypertensive fawn-hooded rat

1 reference

12 December 2020

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

1 reference

12 December 2020

Molecular genetics of Alport syndrome

1 reference

12 December 2020

Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme (ACE) inhibitor

1 reference

12 December 2020

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

1 reference

12 December 2020

The potential for regression of renal scarring

1 reference

12 December 2020

Effect of angiotensin-converting enzyme inhibitor therapy on proteinuria in children with renal disease

1 reference

12 December 2020

Angiotensin converting enzyme inhibitors and reflux nephropathy: 2-year follow-up

1 reference

12 December 2020

Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group

1 reference

12 December 2020

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass

1 reference

12 December 2020

ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy.

1 reference

12 December 2020

Long-term therapy with enalapril in patients with nephrotic-range proteinuria

1 reference

12 December 2020

Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathy

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

1 reference

12 December 2020

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

12 December 2020

Effect of enalapril on proteinuria, phosphaturia, and calciuria in insulin-dependent diabetes.

1 reference

12 December 2020

Combination ACEI and ARB therapy: additional benefit in renoprotection?

1 reference

12 December 2020

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

1 reference

12 December 2020

Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy

1 reference

12 December 2020

Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy

1 reference

12 December 2020

10.1007/S00467-003-1366-Z

Identifiers

DOI

1 reference

5 December 2017

1 reference

PubMed ID

14745635